Skip to main content
Download PDF

Spinocerebellar Ataxia type 29 in a family of Māori descent

Cerebellum & Ataxias volume 6, Article number: 14 (2019) Cite this article

Abstract

Background

Mutations in the Inositol 1,4,5-Trisphosphate Receptor Type 1 (ITPR1) gene cause spinocerebellar ataxia type 29 (SCA29), a rare congenital-onset autosomal dominant non-progressive cerebellar ataxia. The Māori, indigenous to New Zealand, are an understudied population for genetic ataxias.

Case presentation

We investigated the genetic origins of spinocerebellar ataxia in a family of Māori descent consisting of two affected sisters and their unaffected parents. Whole exome sequencing identified a pathogenic variant, p.Thr267Met, in ITPR1 in both sisters, establishing their diagnosis as SCA29.

Conclusions

We report the identification of a family of Māori descent with a mutation causing SCA29, extending the worldwide scope of this disease. Although this mutation has occurred de novo in other populations, suggesting a mutational hotspot, the children in this family inherited it from their unaffected mother who was germline mosaic.

Introduction

The autosomal dominant spinocerebellar ataxias (SCAs) are a heterogeneous group of neurodegenerative disorders that cause cerebellar ataxia and degeneration of the cerebellum and brainstem. These genetic diseases have nearly 50 known subtypes characterized with extra-cerebellar central nervous system manifestations varying by specific genetic type [1]. Spinocerebellar ataxia type 29 (SCA29) is a rare congenital-onset autosomal dominant non-progressive cerebellar ataxia caused by mutations in the inositol 1,4,5-triphosphate receptor type 1 (ITPR1) gene characterized by early-onset hypotonia, gross motor delay, and mild cognitive impairment [2,3,4,5,6]. Distinct mutations in the same gene are also associated with SCA type 15 and Gillespie syndrome [1, 4].

The Māori are the indigenous people of New Zealand, currently representing approximately 15% of the total population of the country (http://worldpopulationreview.com/countries/new-zealand/). To date, there is limited genomic information from this population publically available, and no comprehensive analysis of spinocerebellar ataxia causes has yet been performed. Here, we describe the genetic analysis of two siblings in a family of Māori descent presenting with congenital-onset non-progressive ataxia by whole exome sequencing (WES).

Case report

The Institutional Review Board of UCLA approved all methods for this study. The family was identified during routine clinical evaluation in their native country of New Zealand. The affected sisters (Fig. 1) exhibited non-progressive ataxia with onset from early infancy. The oldest sister was observed to have early delated motor milestones and first walked with crutches at age 7 years. Speech was also delayed with first word at age 5.5 years. By school age, learning difficulties were noted and formal assessment of IQ was 54. Neurological examination as an adult in her mid-forties was notable for strabismus, horizontal nystagmus, and hypermetric saccades to the left with hypometric saccades to the right (saccades were mildly misdirected). Speech exhibited a scanning dysarthria. Motor and sensory systems were intact although tone was decreased and there was a mild tremor. Limb and gait ataxia were present. MRI of the brain showed atrophy of the cerebellum. The younger sister also had early delated motor milestones and first walked with crutches at age 3.5 years. Speech was also delayed with first word at age 3 years. By school age, mild learning difficulties were noted as well and IQ was measured at 73. Neurological examination as an adult in her early-forties was similar to that her sister. MRI of the brain was not performed.

Fig. 1
figure1

Family Pedigree. Pedigree of the family presented in this report. Proband is indicated by an arrow. Shaded symbols represent affected individuals. A dot indicates germline mosaicism. Genotypes of the c.800 position in ITPR1 are shown under each patient sequenced. C is reference and T is p.Thr267Met variant

Full size image

Diagnostic evaluation

The family received comprehensive clinical evaluations for acquired causes of ataxia [7] and, after genetic counseling, provided written informed consent for participation in this research study. The two affected sisters tested negative for common genetic ataxias (SCA1, SCA2, SCA3, SCA6, SCA7, and SCA36). Genomic investigation for causes of spinocerebellar ataxia was performed using whole exome sequencing (WES) on all four members of the family (Fig. 1). The Nextera Rapid Capture Exome Kit (Illumina, San Diego, CA) was used to prepare the genomic DNA (gDNA) libraries. gDNA libraries were sequenced on the HiSeq 2500 sequencer in the rapid-run mode (Illumina, San Diego, CA) as 107-bp paired-end reads. Burrows-Wheeler Aligner (BWA) [8] was used to align sequencing data to the hs37d5 reference and SAMtools [9] was used to post-process the alignment data. Picard Tools (https://broadinstitute.github.io/picard/) was used to compute sequence alignment statistics and marked duplicate reads. Variants were called based on the Broad Institute’s Genome Analysis Toolkit (GATK) version 3 best practices [10, 11]. Family relationships were confirmed by the relatedness algorithm from VCFtools [12]. Variants were annotated with VarSeq (Golden Helix, Inc., Bozeman, MT, www.goldenhelix.com). Variants were classified based off the American College of Medical Genetics and Genomics (ACMG) guidelines [13].

Exome sequencing identified a pathogenic variant in the ITPR1 gene present in both affected sisters. The ITPR1 variant (hg19:chr3:4687357C > T, p.Thr267Met) was previously reported as occurring de novo or sporadically [3,4,5] and is not present in the ExAC (exac.broadinstitute.org) or gnomAD (gnomad.broadinstitute.org) public databases of human variation. In HEK293 cells [5] and in IP3R triple knockout HeLa cells [6], the p.Thr267Met variant showed reduced IP3-induced Ca2+ release suggesting it is a loss of function mutation. Although observed in multiple families [3,4,5], this variant has not previously been reported as inherited through the germline. WES in our data indicated that the variant was present at low level (2/242 reads) in the unaffected mother suggesting she is germline mosaic for the variant.

Discussion and conclusions

There is little published information about genomic variation in the New Zealand Māori population and the prevalence of spinocerebellar ataxia in this population has not been fully studied. To date, there have been 6 reported families with Māori ancestry and spinocerebellar ataxia [14,15,16]. Thus far, patients have been reported with cerebellar ataxia, neuropathy, and vestibular areflexia syndrome (CANVAS) [14], hereditary spastic paraplegia type 7 [15], and autosomal recessive spastic ataxia of Charlevoix-Saguenay [16]. Mutation of the ITPR1 gene is associated with two distinct ataxic phenotypes, a progressive adult-onset form characterized primarily by gait and limb ataxia, termed Spinocerebellar Ataxia Type 15 (SCA15), and a congenital non-progressive form associated with intellectual disability (SCA29) [1, 4]. Here, we provide the first report of SCA29 in a family of Māori ancestry originating from New Zealand. The identified p.Thr267Met mutation was germline inherited from the unaffected Māori mother who is mosaic. The observation of this same variant occurring in multiple families of different ethnic origin, including now the Māori population of New Zealand, suggests this site may be a mutational hotspot within ITPR1. This is supported by a recent study that identified this variant as part of a rare cluster of missense mutations found within the ITPR1 gene [17]. Our findings expand the prevalence and underlying genetic etiology of SCA29. Given the absence of ataxia in other members of the large extended maternal family, we speculate that this mutation occurred within the mother during her early development, resulting in the presence of the mutation in the germline and at a low level in the blood and perhaps other tissues, but sparing her of the neurological phenotype. We have previously observed parental mosaicism in other SCA29 families, both maternally (p.Gly2506Arg) [4] and paternally (p.Arg269Trp, unpublished observation), suggesting that it may be clinically informative to assess the parents of a child with SCA29 for mosaicism to aid in appropriate genetic and reproductive counseling.

Availability of data and materials

The datasets generated and/or analyzed during the current study are not publicly available as they could compromise the anonymity of the subject but specific data elements may be available from the corresponding author on reasonable request.

Abbreviations

ACMG:

American College of Medical Genetics and Genomics

BWA:

Burrows-Wheeler Aligner

GATK:

Genome Analysis Toolkit

gDNA:

Genomic DNA

ITPR1:

Inositol 1,4,5-Trisphosphate Receptor Type 1

SCA:

Spinocerebellar Ataxia

SCA29:

Spinocerebellar Ataxia Type 29

WES:

Whole Exome Sequencing

References

  1. 1.

    Mundwiler A, Shakkottai VG. Autosomal-dominant cerebellar ataxias. Handb Clin Neurol. 2018;147:173–85.

    Article  Google Scholar 

  2. 2.

    Dudding TE, Friend K, Schofield PW, Lee S, Wilkinson IA, Richards RI. Autosomal dominant congenital non-progressive ataxia overlaps with the SCA15 locus. Neurology. 2004;63(12):2288–92.

    CAS  Article  Google Scholar 

  3. 3.

    Sasaki M, Ohba C, Iai M, Hirabayashi S, Osaka H, Hiraide T, et al. Sporadic infantile-onset spinocerebellar ataxia caused by missense mutations of the inositol 1,4,5-triphosphate receptor type 1 gene. J Neurol. 2015;262(5):1278–84.

    CAS  Article  Google Scholar 

  4. 4.

    Zambonin JL, Bellomo A, Ben-Pazi H, Everman DB, Frazer LM, Geraghty MT, et al. Spinocerebellar ataxia type 29 due to mutations in ITPR1: a case series and review of this emerging congenital ataxia. Orphanet J Rare Dis. 2017;12(1):121.

    Article  Google Scholar 

  5. 5.

    Synofzik M, Helbig KL, Harmuth F, Deconinck T, Tanpaiboon P, Sun B, et al. De novo ITPR1 variants are a recurrent cause of early-onset ataxia, acting via loss of channel function. Eur J Hum Genet. 2018;26(11):1623–34.

    CAS  Article  Google Scholar 

  6. 6.

    Ando H, Hirose M, Mikoshiba K. Aberrant IP3 receptor activities revealed by comprehensive analysis of pathological mutations causing spinocerebellar ataxia 29. Proc Natl Acad Sci U S A. 2018;115(48):12259–64.

    CAS  Article  Google Scholar 

  7. 7.

    Fogel BL, Lee H, Deignan JL, Strom SP, Kantarci S, Wang X, et al. Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia. JAMA Neurol. 2014;71(10):1237–46.

    Article  Google Scholar 

  8. 8.

    Li H, Durbin R. Fast and accurate short read alignment with burrows-wheeler transform. Bioinformatics. 2009;25(14):1754–60.

    CAS  Article  Google Scholar 

  9. 9.

    Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The sequence alignment/map format and SAMtools. Bioinformatics. 2009;25(16):2078–9.

    Article  Google Scholar 

  10. 10.

    DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 2011;43(5):491–8.

    CAS  Article  Google Scholar 

  11. 11.

    McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297–303.

    CAS  Article  Google Scholar 

  12. 12.

    Danecek P, Auton A, Abecasis G, Albers CA, Banks E, DePristo MA, et al. The variant call format and VCFtools. Bioinformatics. 2011;27(15):2156–8.

    CAS  Article  Google Scholar 

  13. 13.

    Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5):405–24.

    Article  Google Scholar 

  14. 14.

    Wu TY, Taylor JM, Kilfoyle DH, Smith AD, McGuinness BJ, Simpson MP, et al. Autonomic dysfunction is a major feature of cerebellar ataxia, neuropathy, vestibular areflexia 'CANVAS' syndrome. Brain. 2014;137(Pt 10):2649–56.

    Article  Google Scholar 

  15. 15.

    Roxburgh RH, Marquis-Nicholson R, Ashton F, George AM, Lea RA, Eccles D, et al. The p.Ala510Val mutation in the SPG7 (paraplegin) gene is the most common mutation causing adult onset neurogenetic disease in patients of British ancestry. J Neurol. 2013;260(5):1286–94.

    CAS  Article  Google Scholar 

  16. 16.

    Nickerson SL, Marquis-Nicholson R, Claxton K, Ashton F, Leong IU, Prosser DO, et al. SNP analysis and whole exome sequencing: their application in the analysis of a consanguineous pedigree segregating Ataxia. Microarrays (Basel). 2015;4(4):490–502.

    CAS  Article  Google Scholar 

  17. 17.

    Geisheker MR, Heymann G, Wang T, Coe BP, Turner TN, Stessman HAF, et al. Hotspots of missense mutation identify neurodevelopmental disorder genes and functional domains. Nat Neurosci. 2017;20(8):1043–51.

    CAS  Article  Google Scholar 

Download references

Acknowledgements

The authors wish to thank the patients and their family for their contributions to this study. The authors also thank Jessica Rexach, MD, PhD, and UCLA Neuroscience Genomics Core (UNGC) of the University of California at Los Angeles for technical assistance.

Funding

This work was supported in part by the National Institute for Neurological Disorders and Stroke (grant R01NS082094 to Dr. Fogel), and the National Ataxia Foundation (Young Investigator Award to Dr. Fogel). The research described was supported by the National Institutes of Health/National Center for Advancing Translational Science UCLA Clinical and Translational Science Institute grant UL1TR000124. Dr. Fogel acknowledges the support through donations to the University of California by the Rochester Ataxia Foundation.

Author information

Affiliations

  1. Program in Neurogenetics, Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, 695 Charles E. Young Drive South, Gonda Room 6554, Los Angeles, CA, 90095, USA

    Kathie J. Ngo & Brent L. Fogel

  2. Genetic Health Service NZ, Wellington, New Zealand

    Gemma Poke & Katherine Neas

  3. Department of Human Genetics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA

    Brent L. Fogel

Authors
  1. Kathie J. Ngo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gemma Poke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Katherine Neas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Brent L. Fogel
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

GP, KN, and BLF contributed to the conception and design of the research project and KJN was responsible for its execution. GP and KN were responsible for collection of the clinical data, samples, and/or managed patient care. KJN conducted all bioinformatics analysis. KJN and BLF wrote the manuscript and all authors were responsible for its review and critique. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Brent L. Fogel.

Ethics declarations

Ethics approval and consent to participate

The Institutional Review Board of UCLA approved all methods for this study. After genetic counseling, the family provided written informed consent for participation in this research study.

Consent for publication

Not applicable.

Competing interests

The authors report no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ngo, K.J., Poke, G., Neas, K. et al. Spinocerebellar Ataxia type 29 in a family of Māori descent. cerebellum ataxias 6, 14 (2019). https://doi.org/10.1186/s40673-019-0108-3

Download citation

Keywords

  • Cerebellar Ataxia
  • Spinocerebellar Ataxia
  • SCA29
  • Neurogenetics
  • Gait disorders/ataxia
  • Māori
  • Genetic testing

Cerebellum & Ataxias

ISSN: 2053-8871